Market News How it works Learn FAQ
| RCT 0.0923 21.29% | NU 12.5021 -17.53% | EWZ 34.02 -20.12% | BBD 2.877 -29.31% | TGL 0.2429 9.66% | AZTR 2.05 186.71% | ITUB 7.68 -20.58% | SRTM 0.2775 -35.51% | NVD 3.995 -4.65% | XP 15.4801 -49.10% | WFF 0.089 11.25% | SHFS 0.091 -31.27% | SPCX 149.37 1.27% | SOXL 92.37 10.54% | PBR 22.715 -13.17% | VALE 11.99 -3.31% | CLRO 4.84 48.92% | INTC 91.75 5.51% | GCDT 0.1443 -18.06% | TSLL 10.885 11.53% | NWGL 0.0872 6.34% | NOK 8.715 7.06% | NVDA 216.1126 2.44% | SOXS 46.95 -10.50% | CRWV 56.22 3.66% | BITO 10.695 -1.25% | RWM 14.475 -0.52% | GPUS 0.1858 10.01% | SGRY 23.185 47.21% | TSLG 5.445 11.81% | ABEV 2.805 -15.00% | JBLU 2.285 -12.95% | IREN 26.025 4.50% | INTR 4.595 -36.09% | RBNE 0.1682 -11.47% | QID 14.1701 -2.61% | AAL 12.1792 0.57% | TQQQ 68.8286 3.83% | SBS 4.6303 -27.65% | SPDN 8.485 -0.64% | TSLA 393.84 5.81% | T 20.6998 -1.10% | LUCD 0.538 30.90% | SID 0.9075 -23.09% | WULF 12.3201 8.83% | XTND 2.2899 29.37% | NFLX 63.005 -4.32% | CIFR 7.885 -0.69% | SQQQ 38.17 -3.81% | RIG 6.555 2.26%
BBBeta Bionics, Inc. logo

Beta Bionics, Inc. (BBNX)

NASDAQ Global Market · Currency in USD
$20.58 ▲ +1.42 (+7.39%)
As of Oct 26, 3:14 PM ET. Market open.

Summary

Previous Close
$19.16
Open
$19.08
Day's Range
$19.08 – $20.60
52 Week Range
$8.80 – $32.71
Volume
579,981
Avg. Volume
1,215,462
Market Cap
$925.66M
Beta (5Y Monthly)
3.38
PE Ratio (TTM)
--
EPS (TTM)
-$1.64
Earnings Date
Oct 27, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$24.75

Profile: Beta Bionics, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
422
CEO
Sean T. Saint

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes.

Earnings

Next report: Tue, Oct 27, 2026
EPS estimate -$0.52 · Revenue est. $34.72M
DateEst.Actual
Jul 29, 2026-$0.58-$0.53Beat
Apr 21, 2026-$0.53-$0.49Beat
Feb 17, 2026-$0.42-$0.30Beat
Oct 28, 2025-$0.45-$0.33Beat
Jul 29, 2025-$0.51-$0.39Beat
May 6, 2025-$0.51-$0.52Miss

Analyst view

Consensus price target
$24.75 ▲ +20.3%
Range $16.00 – $30.00
Rating: Buy
Buy 75% · Hold 25% · Sell 0%

Get free alerts on BBNX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.